SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-000952
Filing Date
2021-01-04
Accepted
2021-01-04 16:10:32
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 d282609d424b5.htm 424B5 861987
2 GRAPHIC g282609g08v00.jpg GRAPHIC 143325
3 GRAPHIC g282609g10a54.jpg GRAPHIC 93016
4 GRAPHIC g282609g10b44.jpg GRAPHIC 62670
5 GRAPHIC g282609g11a01.jpg GRAPHIC 66259
6 GRAPHIC g282609g11a02.jpg GRAPHIC 99664
7 GRAPHIC g282609g11w36.jpg GRAPHIC 42915
8 GRAPHIC g282609g11x11.jpg GRAPHIC 108791
9 GRAPHIC g282609g33g69.jpg GRAPHIC 115119
10 GRAPHIC g282609g57a35.jpg GRAPHIC 39364
  Complete submission text file 0001193125-21-000952.txt   1912589
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238991 | Film No.: 21501875
SIC: 2834 Pharmaceutical Preparations